: Hepatocellular carcinoma (advanced and metastatic) - sorafenib (first line)
This is a discussion on : Hepatocellular carcinoma (advanced and metastatic) - sorafenib (first line) within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Hepatocellular carcinoma (advanced and metastatic) - sorafenib (first line). It links to the ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
05-25-2010, 09:42 PM
|
|||
|
|||
: Hepatocellular carcinoma (advanced and metastatic) - sorafenib (first line)
The summary for the published technology appraisal on Hepatocellular carcinoma (advanced and metastatic) - sorafenib (first line). It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA147: Breast cancer (advanced & metastatic) - bevacizumab (terminated appraisal) | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA169: Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma | industry_news | Updates from the Technology Assessment Authorities | 0 | 03-24-2009 09:20 PM |
| First-Line Chemo for Small-Cell Lung Cancer is Not Superior to Second-Line | industry_news | Other Clinical Pharmacy News | 0 | 10-08-2008 09:21 AM |
| Sorafenib Increases Survival in Advanced Liver Cancer | industry_news | Other Clinical Pharmacy News | 0 | 07-25-2008 07:50 AM |
| Everolimus Potential Alternative for Metastatic Renal Cell Carcinoma | industry_news | Other Clinical Pharmacy News | 0 | 07-24-2008 11:51 AM |
© 2008 DrugManagementForum™ powered by |
 |